HaCaT keratinocyte in silico inputs
Revision as of 15:42, 31 May 2019 by Muttley93 (talk | contribs) (Created page with " Return to overview {| class="wikitable" ! style="font-weight:bold;" | Treatment ! style="font-weight:bold;" | A2...")
Treatment | A23187 | Indomethacin + A23187 | ATP | UVR |
---|---|---|---|---|
Σ AA released
(pg/million cells) |
2.03E+06 | 1.64E+06 | 8.43E+05 | 1.80E+06 |
Σ AA released (mM) | 5.77E-04 | 4.65E-04 | 2.40E-04 | 5.11E-04 |
COX-1 (mM) at 0h | x | 1.00E-28 | x | x |
COX-2 (mM) at 0h | x | 0.00E+00 | x | 0.00E+00 |
COX-2 (mM) at 6h | x | x | x | 2.27E-02 |